BDBM50100381 5-Oxo-hexanoic acid {1-[((S)-1-carbamoyl-2-thiophen-2-yl-ethylcarbamoyl)-methyl]-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[b]azepin-3-yl}-amide::CHEMBL285608
SMILES: CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2cccs2)C(N)=O)C1=O
InChI Key: InChIKey=JRKMSSIREGTHDQ-QASNXKAYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxytocin receptor (Homo sapiens (Human)) | BDBM50100381 (5-Oxo-hexanoic acid {1-[((S)-1-carbamoyl-2-thiophe...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Medicines Research Centre Curated by ChEMBL | Assay Description Inhibitory concentration required for antagonist activity against oxytocin receptor | Bioorg Med Chem Lett 11: 1297-300 (2001) BindingDB Entry DOI: 10.7270/Q2T72GQF | |||||||||||
More data for this Ligand-Target Pair |